IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,841,416 | +11.7% | 283,100 | +1.1% | 0.01% | +25.0% |
| Q2 2023 | $11,492,503 | +16.5% | 280,100 | +1.5% | 0.01% | +14.3% |
| Q1 2023 | $9,860,666 | -15.3% | 275,900 | -10.5% | 0.01% | -12.5% |
| Q4 2022 | $11,648,268 | -13.0% | 308,400 | +1.9% | 0.01% | -20.0% |
| Q3 2022 | $13,384,000 | +20.8% | 302,600 | +1.1% | 0.01% | +42.9% |
| Q2 2022 | $11,080,000 | -0.5% | 299,300 | -0.4% | 0.01% | +16.7% |
| Q1 2022 | $11,131,000 | +31.0% | 300,500 | +7.6% | 0.01% | +20.0% |
| Q4 2021 | $8,499,000 | -9.5% | 279,300 | -0.2% | 0.01% | -16.7% |
| Q3 2021 | $9,388,000 | -15.9% | 279,900 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $11,165,000 | -51.3% | 279,900 | -45.2% | 0.01% | -53.3% |
| Q1 2021 | $22,946,000 | -19.1% | 510,359 | +1.7% | 0.02% | -25.0% |
| Q4 2020 | $28,364,000 | +16.0% | 501,659 | -2.7% | 0.02% | +5.3% |
| Q3 2020 | $24,459,000 | -21.5% | 515,459 | -2.5% | 0.02% | -26.9% |
| Q2 2020 | $31,158,000 | +27.0% | 528,459 | +1.9% | 0.03% | 0.0% |
| Q1 2020 | $24,527,000 | -3.5% | 518,759 | +23.3% | 0.03% | 0.0% |
| Q4 2019 | $25,424,000 | -3.6% | 420,859 | -4.4% | 0.03% | -7.1% |
| Q3 2019 | $26,370,000 | -4.3% | 440,159 | +2.7% | 0.03% | -6.7% |
| Q2 2019 | $27,553,000 | +42.6% | 428,700 | +80.1% | 0.03% | +42.9% |
| Q1 2019 | $19,327,000 | +55.0% | 238,100 | +3.3% | 0.02% | +31.2% |
| Q4 2018 | $12,466,000 | +10.4% | 230,600 | +5.3% | 0.02% | +23.1% |
| Q3 2018 | $11,291,000 | +25.0% | 218,900 | +1.0% | 0.01% | +30.0% |
| Q2 2018 | $9,030,000 | -5.5% | 216,700 | 0.0% | 0.01% | -16.7% |
| Q1 2018 | $9,552,000 | -10.3% | 216,700 | +2.3% | 0.01% | 0.0% |
| Q4 2017 | $10,654,000 | +1.4% | 211,800 | +2.2% | 0.01% | 0.0% |
| Q3 2017 | $10,510,000 | +2.3% | 207,300 | +2.7% | 0.01% | 0.0% |
| Q2 2017 | $10,271,000 | +27.6% | 201,900 | +0.8% | 0.01% | +20.0% |
| Q1 2017 | $8,048,000 | -15.4% | 200,200 | +0.7% | 0.01% | -33.3% |
| Q4 2016 | $9,509,000 | +9.9% | 198,800 | -15.8% | 0.02% | +7.1% |
| Q3 2016 | $8,654,000 | +9.9% | 236,200 | -30.2% | 0.01% | +7.7% |
| Q2 2016 | $7,877,000 | -35.0% | 338,200 | +8.4% | 0.01% | -40.9% |
| Q1 2016 | $12,114,000 | -9.9% | 312,100 | +43.8% | 0.02% | -33.3% |
| Q4 2015 | $13,439,000 | – | 217,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |